Investors

Biography

Saniona Icon blue
Kyle Haraldsen

Kyle Haraldsen

Chief Technical Operations Officer
Kyle Haraldsen (born 1978) has nearly 20 years of technical operations and manufacturing experience in the biopharmaceutical industry, including in support of U.S. and E.U. product approvals. Prior to joining Saniona in January 2021, he served as the Vice President of Technical Operations and Project Management at AMAG Pharmaceuticals, where over a 7 year period, he led the process and analytical development, manufacturing, supply chain and project management functions. During his time at AMAG, Haraldsen oversaw multiple product launches, line extensions and the integration of two development stage assets.

Previously, Haraldsen served as Senior Director of Manufacturing at Radius Health where he was responsible for the developmental, operational, and budgetary oversight of CMC programs and clinical trial material in support of global Phase 3 and multinational Phase 2 clinical trials. Haraldsen also worked for Avecia Biotechnology and Johnson Matthey Pharma Services.

He holds a B.S. in Chemical Engineering from Northeastern University.

Haraldsen holds 4,200 shares and 228,000 options in the options program 2020/2031.